AVANOS MEDICAL, INC. (AVNS)

11.49 -0.1 (-0.86%)

As of 2025-12-02 07:28:24 EST

Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.

Traded asNYSE: AVNS
ISINUS05350V1061
CIK0001606498
LEI549300YCXWOM7NEWMQ58
EIN464987888
SectorHealthcare
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
CEOJoseph F. Woody
Employees5,380
Fiscal Year End1231
Address5405 WINDWARD PARKWAY, ALPHARETTA, GA, 30004
Phone844-428-2667
Websitehttps://avanos.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
AVNSAVANOS MEDICAL, INC.2025-12-02 07:28:2411.49-0.1-0.86
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
AVNS0001606498AVANOS MEDICAL, INC.US05350V1061549300YCXWOM7NEWMQ58464987888NYSE3842Orthopedic, Prosthetic & Surgical Appliances & Supplies1231DE5405 WINDWARD PARKWAYALPHARETTAGA30004UNITED STATESUS844-428-26675405 WINDWARD PARKWAY, ALPHARETTA, GA, 300045405 WINDWARD PARKWAY, ALPHARETTA, GA, 30004Halyard Health, Inc.Healthcare2014Joseph F. Woody5,380https://avanos.com/907,273,47146,614,94746,418,907Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.2025-11-27 17:46:45
This is a preview of the latest data. Subscribe to access the full data.
AVNS Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
AVNS Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024907,273,471-284,441,490-23.868246,003,150-199,842-0.4325
20231,191,714,961-87,419,747-6.834346,202,992-395,903-0.8496
20221,279,134,708-468,429,753-26.804746,598,895-719,021-1.5196
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Kerr W. HolbrookChief Commercial Officer, Senior Vice President2024500,00001,400,000264,72033,2782,197,998
Mojirade A. JamesSecretary, General Counsel, Senior Vice President2024471,50001,175,000230,42936,2921,913,221
Michael C. GreinerChief Executive Officer2024772,08303,390,297471,66067,5094,701,549
Warren J. MachanChief Financial Officer2024332,5000000332,500
Joseph F. WoodyChief Executive Officer20241,088,34805,249,9871,064,40491,9707,494,709
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20194,700
20184,700
201713,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue687,800,000673,300,000820,000,000
Cost Of Revenue306,500,000293,600,000370,000,000
Gross Profit381,300,000379,700,000450,000,000
Research And Development Expenses26,200,00027,200,00030,600,000
General And Administrative Expenses318,500,000335,000,000341,900,000
Operating Expenses———
Operating Income-396,200,0004,200,00074,000,000
Net Income-392,100,000-61,800,00050,500,000
Earnings Per Share Basic-8.53-1.321.08
Earnings Per Share Diluted-8.53-1.321.07
Weighted Average Shares Outstanding Basic46,000,00046,600,00046,900,000
Weighted Average Shares Outstanding Diluted46,000,00046,600,00047,300,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents107,700,00087,700,000127,700,000
Marketable Securities Current———
Accounts Receivable132,800,000142,800,000167,900,000
Inventories138,800,000163,200,000190,300,000
Non Trade Receivables4,900,00014,100,00012,200,000
Other Assets Current———
Total Assets Current393,400,000487,000,000499,800,000
Marketable Securities Non Current———
Property Plant And Equipment110,700,000117,200,000163,900,000
Other Assets Non Current23,200,00019,300,00017,600,000
Total Assets Non Current760,800,0001,205,400,0001,287,100,000
Total Assets1,154,200,0001,692,400,0001,786,900,000
Accounts Payable54,300,00056,300,00067,900,000
Deferred Revenue———
Short Term Debt9,400,0008,600,0006,200,000
Other Liabilities Current91,300,00093,200,00098,900,000
Total Liabilities Current165,900,000234,600,000185,800,000
Long Term Debt125,300,000159,400,000226,300,000
Other Liabilities Non Current4,400,00010,000,00023,500,000
Total Liabilities Non Current159,800,000221,500,000309,900,000
Total Liabilities325,700,000456,100,000495,700,000
Common Stock500,000500,000500,000
Retained Earnings-707,000,000-314,900,000-253,100,000
Accumulated Other Comprehensive Income-44,600,000-27,000,000-35,800,000
Total Shareholders Equity828,500,0001,236,300,0001,291,200,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization45,500,00046,100,00047,700,000
Share Based Compensation Expense13,800,00015,800,00015,900,000
Other Non Cash Income Expense-1,200,000——
Change In Accounts Receivable6,600,000-39,000,00024,700,000
Change In Inventories-39,000,000-4,700,00030,900,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-900,000-14,400,00035,400,000
Change In Other Liabilities-11,400,000-27,700,000-7,100,000
Cash From Operating Activities100,700,00032,400,00090,900,000
Purchases Of Marketable Securities——0
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment17,800,00017,800,00019,300,000
Acquisition Of Business049,600,000116,100,000
Other Investing Activities———
Cash From Investing Activities-27,500,00021,600,000-135,400,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock12,800,00019,100,00045,500,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt45,000,000115,000,000170,000,000
Other Financing Activities———
Cash From Financing Activities-49,100,000-94,200,00056,700,000
Change In Cash20,000,000-40,000,0009,200,000
Cash At End Of Period107,700,00087,700,000127,700,000
Income Taxes Paid———
Interest Paid11,500,00014,700,0008,100,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-8.53-1.321.08
Price To Earnings Ratio-1.8664-16.992425.0556
Earnings Growth Rate546.2121-222.2222881.8182
Price Earnings To Growth Ratio-0.00340.07650.0284
Book Value Per Share18.010926.5327.5309
Price To Book Ratio0.88390.84550.9829
Ebitda-334,400,000-700,000108,200,000
Enterprise Value759,320,0001,125,538,0001,373,914,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.16260.13590.1801
Capital Expenditures39,000,000-600,00043,500,000
Free Cash Flow61,700,00033,000,00047,400,000
Return On Equity-0.4733-0.050.0391
One Year Beta0.96771.18620.9175
Three Year Beta0.96760.95311.118
Five Year Beta1.10991.12921.0845
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Holbrook KerrSVP, Chief Commercial Officer2025-11-1813,834D85,026
Holbrook KerrSVP, Chief Commercial Officer2025-11-18100D84,926
Holbrook KerrSVP, Chief Commercial Officer2025-11-18761D84,165
Holbrook KerrSVP, Chief Commercial Officer2025-11-18305D83,860
Hurley John JosephPrincipal Accounting Officer2025-09-05345D11,364
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Nicholas Van Taylor2020-04-13TX03Sale2020-03-17—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
JPMORGAN CHASE & CO2025-09-306,680,397577,88911.56
CIBC Private Wealth Group LLC2025-09-309,07578511.5605
Sunbelt Securities, Inc.2025-09-302892511.56
CAPTRUST FINANCIAL ADVISORS2025-09-30164,56814,23611.56
Caitong International Asset Management Co., Ltd2025-09-3016,6461,44011.5597
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
RYDEX SERIES FUNDS2025-09-30Class CRYCMX63728.280.0109
RYDEX SERIES FUNDS2025-09-30Class ARYAKX63728.280.0109
RYDEX SERIES FUNDS2025-09-30Class HRYMKX63728.280.0109
RYDEX SERIES FUNDS2025-09-30Class HRYRHX1051,213.80.0098
RYDEX SERIES FUNDS2025-09-30Class CRYROX1051,213.80.0098
This is a preview of the latest data. Subscribe to access the full data.